BEAMTREE HOLDINGS LIMITED (BMT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

BMT

BMT - BEAMTREE HOLDINGS LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 29.03
Index:

0

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.115

02 Sep
2026

0.010

OPEN

$0.10

9.52%

HIGH

$0.12

146,929

LOW

$0.10

OTHER COMPANIES IN THE SAME SECTOR
ACL . ALC . DOC . EBO . HLS . IDX . M7T . MPL . MVF . NHF . RHC . SHL .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx-6.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx29.2 M
Book Value Per Share xxxxxxxxxxxxxxx8.0
Net Operating Cash Flow xxxxxxxxxxxxxxx0.9 M
Net Profit Margin xxxxxxxxxxxxxxx-62.59 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx-55.98 %
Return on Invested Capital xxxxxxxxxxxxxxx-53.07 %
Return on Assets xxxxxxxxxxxxxxx-39.86 %
Return on Equity xxxxxxxxxxxxxxx-55.98 %
Return on Total Capital xxxxxxxxxxxxxxx-13.75 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx0.8 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx4 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx4 M
Goodwill - Gross xxxxxxxxxxxxxxx21 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx3 M
Price To Book Value xxxxxxxxxxxxxxx1.74

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx3.9 M
Capex % of Sales xxxxxxxxxxxxxxx13.34 %
Cost of Goods Sold xxxxxxxxxxxxxxx30 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx4 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Shaw and Partners

01/09/2026

1

Buy

$0.25

117.39%

Shaw and Partners maintains a Buy rating for Beamtree Holdings with its target price decreased to $0.25 from $0.30 following an FY26 result featuring revenue of $29.2m and cash EBITDA loss of -$3.5m.

The company delivered 10% recurring revenue growth and finalised a strategic review resetting its product portfolio and operating cost base.

Restructuring initiatives generated an estimated $2m in gross annualised savings and included a -$13.1m write-down of intangibles to concentrate investment strictly on coding, diagnostics, and analytics platforms.

Shaw expects new leadership to drive double-digit growth from a starting FY27 underlying annual recurring revenue base of $25.4m.

The revised valuation reflects lower near-term cash flow forecasts stemming from the strategic reset.

FORECAST
Shaw and Partners forecasts a full year FY27 dividend of 0.00 cents and EPS of minus -0.30 cents.
Shaw and Partners forecasts a full year FY28 dividend of 0.00 cents and EPS of 0.10 cents.
Access Extra Coverage Research History >

BMT STOCK CHART

FNArena News on BMT

1
Australian Broker Call *Extra* Edition – Sep 01, 2026

Sep 01 2026 - Daily Market Reports
2
FNArena Corporate Results Monitor – 20-02-2026

Feb 20 2026 - Australia
3
FNArena Corporate Results Monitor – 29-08-2025

Aug 29 2025 - Australia
4
Australian Broker Call *Extra* Edition – Jun 12, 2025

Jun 12 2025 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – May 12, 2025

May 12 2025 - Daily Market Reports

Latest Healthcare services News

1
Treasure Chest: Beware Aussie Healthcare

Jul 17 2026 - Treasure Chest
2
Major UK Win Highlights Alcidion’s Potential

May 27 2026 - Small Caps
3
Better Times Ahead For Sonic Healthcare?

Jun 20 2025 - Australia
4
The Significance Of Cosmetique’s ASX Listing

Feb 26 2025 - Small Caps
5
Building The No 3 Diagnostic Imaging Player

Jun 19 2024 - Small Caps
6
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
7
Treasure Chest: Ramsay Health Care

Oct 26 2023 - Treasure Chest
8
Timing Seems Right For Alcidion Group

Jun 21 2023 - Small Caps
9
No Enthusiasm To Combine ACL & Healius

Mar 21 2023 - Australia
10
Dr Boreham’s Crucible: Alcidion

Dec 13 2022 - Small Caps